Ophthalmology · New York, NY
NPI
1033364476
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
40 Waterside Plz, Apt 5k
New York, NY, 10010
Phone (212) 920-5835
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
624 services
Medicare patients, 2024
180
Average age 76
Drug cost, 2024
$951K
4,749 prescriptions
Company payments, 2025
$385
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James F Kelly was code 92014 (ophthalmological e&m), 164 times for 138 patients. In total James F Kelly billed 624 services in 17 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 164 | 138 | $95.77 | $16K |
| 92250 Angiography | Office | 151 | 135 | $28.89 | $4,362 |
| 92012 Ophthalmological E&M | Office | 105 | 82 | $73.93 | $7,763 |
| 92083 Vision, Hearing, and Speech Services | Office | 72 | 68 | $52.87 | $3,807 |
| 92133 Computerized Ophthalmic Imaging | Office | 57 | 56 | $28.94 | $1,649 |
| 92020 Ophthalmological E&M | Office | 15 | 15 | $22.10 | $331 |
| 76514 Ultrasound - Nonspecific | Office | 11 | 11 | $7.51 | $82.58 |
By year: 2022 $33K for 531 services; 2023 $37K for 598 services; 2024 $39K for 624 services.
Medicare prescription drug claims, 2024
In 2024, the drug James F Kelly prescribed most often to Medicare patients was Latanoprost, with 1,234 prescriptions and refills. In total James F Kelly wrote 4,749 Medicare prescriptions that cost $951K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,234 | 2,447 | 333 | $12K |
| Restasis Cyclosporine | 458 | 791 | 169 | $473K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 373 | 630 | 94 | $5,455 |
| Timolol Maleate Generic | 372 | 713 | 114 | $6,114 |
| Erythromycin Erythromycin Base | 369 | 369 | 165 | $3,398 |
| Prednisolone Acetate Generic | 331 | 471 | 171 | $16K |
| Brimonidine Tartrate Generic | 275 | 549 | 83 | $44K |
| Ketorolac Tromethamine Generic | 161 | 181 | 79 | $3,044 |
| Lumigan Bimatoprost | 131 | 248 | 37 | $67K |
| Restasis Multidose Cyclosporine | 124 | 131 | 45 | $78K |
| Simbrinza Brinzolamide/Brimonidine Tart | 115 | 156 | 30 | $25K |
| Combigan Brimonidine Tartrate/Timolol | 101 | 180 | 32 | $38K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 90 | 93 | 59 | $721 |
| Dorzolamide Hcl Generic | 90 | 146 | 23 | $1,187 |
| Xiidra Lifitegrast | 89 | 127 | 33 | $82K |
Brand drugs: 2,043 claims; generic drugs: 2,706 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James F Kelly $385 ($385 in general payments such as food, travel and fees) from 8 companies. The largest payer was Johnson & Johnson Surgical Vision, Inc. with $134.
| Company | Payments | Amount |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $134 |
| Dompe US, Inc. | 3 | $79.1 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $40.65 |
| Carl Zeiss Meditec USA, Inc. | 1 | $36.06 |
| Boston Scientific Corporation BSX | 1 | $34.93 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $22.19 |
| Abbvie Inc. ABBV | 1 | $22.19 |
| Surgical Specialties Corporation (us), Inc. (dba Corza Medical) | 1 | $15.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.